EXOZYMES INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-09-22: Application 17934560; Invention PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY; Applicant INVIZYNE TECHNOLOGIES, INC.; Status Patented Case.
- 2022-05-25: Application 17824118; Invention PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY; Applicant INVIZYNE TECHNOLOGIES, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-22 | 17934560 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | INVIZYNE TECHNOLOGIES, INC. | Patented Case | 2024-09-10 | 12084689 | US20230098978A1 | Tyler P. KORMAN | United States | RAGHU, GANAPATHIRAM |
| 2022-05-25 | 17824118 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | INVIZYNE TECHNOLOGIES, INC. | Patented Case | 2022-12-06 | 11518983 | US20220403349A1 | Tyler P. KORMAN | United States | RAGHU, GANAPATHIRAM |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |